Invenomic Capital Management’s Frontdoor FTDR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-662,562
Closed -$22.4M 158
2024
Q2
$22.4M Sell
662,562
-409,883
-38% -$13.8M 1.09% 28
2024
Q1
$34.9M Buy
1,072,445
+390,610
+57% +$12.7M 1.86% 12
2023
Q4
$24M Sell
681,835
-267,871
-28% -$8.91M 1.1% 26
2023
Q3
$29.1M Sell
949,706
-245,902
-21% -$8.15M 1.22% 23
2023
Q2
$38.1M Sell
1,195,608
-112,308
-9% -$3.34M 1.93% 13
2023
Q1
$36.5M Sell
1,307,916
-621,841
-32% -$16.4M 2.06% 13
2022
Q4
$40.1M Buy
1,929,757
+1,116,578
+137% +$24.5M 2.72% 3
2022
Q3
$16.6M Buy
813,179
+330,970
+69% +$8.11M 1.42% 23
2022
Q2
$11.6M Buy
482,209
+300,766
+166% +$8.12M 0.82% 39
2022
Q1
$4.36M Buy
+181,443
New +$6.04M 0.47% 65

Other funds holding FTDR

Invenomic Capital Management's FTDR Position: Q3 2024 in Review

Invenomic Capital Management sold out of Frontdoor (FTDR) in Q3 2024, closing a stake of 662,562 shares — an estimated $22.4M sold.

Invenomic Capital Management first reported a position in FTDR in Q1 2022 and held it in 10 quarters. The position peaked at $40.1M in Q4 2022. 330 funds tracked by Wall St. Rank hold FTDR as of Q3 2024.

  • Invenomic Capital Management reported no remaining Frontdoor position as of Q3 2024 after selling out during the quarter.
  • Invenomic Capital Management sold 662,562 Frontdoor shares in Q3 2024, an estimated $22.4M.
  • Invenomic Capital Management first reported a position in Frontdoor in Q1 2022 and held it in 10 quarters.
  • Invenomic Capital Management's Frontdoor position peaked at $40.1M in Q4 2022.
  • 330 funds tracked by Wall St. Rank held Frontdoor as of Q3 2024.

Based on Invenomic Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.